Husam Abazid
Impact in
-
- Antibiotic Use and Resistance
-
- Therapeutic Uses of Natural Elements
Papers in
-
- COVID-19 and Mental Health 3
- Co-authors
- Ahmad R. Alsayed (3 shared papers)Mohammad A. A. Al‐Najjar (1 shared paper)Iman A. Basheti (3 shared papers)Rana Abu Farha (3 shared papers)Mohammad Amin Mohammad (1 shared paper)Samer Hasan Hussein‐Al‐Ali (1 shared paper)Sahar M. Jaffal (2 shared papers)Muna Barakat (2 shared papers)
- Journals
- Pharmacy Practice (2 papers)Neurochemical Research (1 paper)International Journal of Applied Pharmaceutics (1 paper)Saudi Pharmaceutical Journal (1 paper)Heliyon (1 paper)
- Partner nations
- JordanTürkiyeUnited States
In The Last Decade
Husam Abazid
13 papers receiving 79 citations
Peers
Comparison fields: 5 of 56
- Applied Microbiology and Biotechnology 10
- Complementary and Manual Therapy 8
- Geriatrics and Gerontology 4
- Molecular Medicine 5
- Pharmaceutical Science 5
Countries citing papers authored by Husam Abazid
This map shows the geographic impact of Husam Abazid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Husam Abazid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Husam Abazid more than expected).
Fields of papers citing papers by Husam Abazid
This network shows the impact of papers produced by Husam Abazid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Husam Abazid. The network helps show where Husam Abazid may publish in the future.
Co-authors
The 12 scholars most cited alongside Husam Abazid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 20 | |
| 2 | 2017 | 16 | |
| 3 | 2021 | 10 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2019 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2025 | 0 |
About Husam Abazid
Husam Abazid is a scholar working on Clinical Psychology, Small Animals, Pharmacology, Epidemiology and Economics and Econometrics, having authored 14 papers that have together received 80 indexed citations. Recurring topics across this work include COVID-19 and Mental Health (3 papers), Substance Abuse Treatment and Outcomes (2 papers), COVID-19 Pandemic Impacts (2 papers), Clay minerals and soil interactions (1 paper), Antibiotic Use and Resistance (1 paper), Coffee research and impacts (1 paper), Opioid Use Disorder Treatment (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (10 citations), Complementary and Manual Therapy (8 citations), Geriatrics and Gerontology (4 citations), Molecular Medicine (5 citations) and Pharmaceutical Science (5 citations). Husam Abazid has collaborated with scholars based in Jordan, Türkiye and United States. Frequent co-authors include Ahmad R. Alsayed, Mohammad A. A. Al‐Najjar, Iman A. Basheti, Rana Abu Farha, Mohammad Amin Mohammad, Samer Hasan Hussein‐Al‐Ali, Sahar M. Jaffal, Muna Barakat, Rajaa Alqudah and Alaa M. Hammad. Their work appears in journals such as Pharmacy Practice, Neurochemical Research, International Journal of Applied Pharmaceutics, Saudi Pharmaceutical Journal and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.